← Back to Search

Behavioural Intervention

Inspiratory Muscle Training vs Aerobic Exercise for High Blood Pressure

N/A
Recruiting
Led By Douglas R Seals, PhD
Research Sponsored by University of Colorado, Boulder
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No change in blood pressure medications or other medications (prescription or dosing) in the prior 3 months and willing to maintain current medication regimen
Postmenopausal women (>12 months of amenorrhea)
Must not have
History of uncontrolled hypertension (systolic blood pressure >180 mmHg and/or diastolic blood pressure >120 mmHg)
Younger than age 50 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a breathing exercise called high-resistance inspiratory muscle strength training (IMST) for postmenopausal women aged 50 and older with high blood pressure. IMST involves breathing in against resistance for a short period each day. It aims to lower blood pressure and improve blood vessel function by reducing harmful molecules and increasing helpful ones. High-resistance inspiratory muscle strength training (IMST) is a novel, time-efficient physical training modality.

Who is the study for?
This trial is for postmenopausal women aged 50 or older with high blood pressure (systolic BP ≥120 mmHg). Participants should not be on hormone therapy, have a BMI under 40, and must not have had significant weight changes or medication adjustments recently. They shouldn't smoke, abuse alcohol, or engage in regular intense exercise.
What is being tested?
The study compares the effects of high-resistance inspiratory muscle strength training (IMST) versus standard aerobic exercise like brisk walking on lowering blood pressure and improving vascular health in postmenopausal women over three months.
What are the potential side effects?
Potential side effects are not explicitly listed but may include muscle fatigue from IMST and typical exercise-related risks such as joint strain from brisk walking. The safety profile will likely be clarified during the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't changed my blood pressure or any other medications in the last 3 months and am willing to keep them the same.
Select...
I am a woman who has not had a period for over 12 months.
Select...
I am 50 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have uncontrolled high blood pressure.
Select...
I am under 50 years old.
Select...
I experienced menopause before the age of 45.
Select...
I have had a hysterectomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in casual systolic and diastolic blood pressure at 3 months
Secondary study objectives
Change from baseline endothelial function at 3 months
Change from baseline in ambulatory systolic and diastolic blood pressure at 3 months
Other study objectives
Adherence to the intervention
Change from baseline in endothelial cell nitric oxide production at 3 months
Change from baseline in endothelial cell oxidative stress at 3 months
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-resistance inspiratory muscle strength trainingExperimental Treatment1 Intervention
Using a handheld device, participants will perform 30 breaths a day at 75% of maximal inspiratory pressure, six days a week, for three months.
Group II: Aerobic exerciseActive Control1 Intervention
Participants will walk for 25 minutes a day, six days a week, for three months at a target heart rate of 40-60% heart rate reserve. Heart rate will be monitored with a heart rate monitor.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for high blood pressure, such as High-Resistance Inspiratory Muscle Strength Training (IMST), work by reducing oxidative stress and increasing nitric oxide bioavailability. These mechanisms help relax blood vessels, improve endothelial function, and reduce vascular resistance, which are essential for lowering blood pressure. This is particularly important for high blood pressure patients as it helps mitigate the risk of cardiovascular diseases and improves overall vascular health.
Resistance training to reduce resting blood pressure and increase muscle strength in users and non-users of anti-hypertensive medication: A meta-analysis.[Respiratory physiotherapy in post-acute COVID-19 adult patients: Systematic review of literature].Molecular Regulation of Skeletal Muscle Growth and Organelle Biosynthesis: Practical Recommendations for Exercise Training.

Find a Location

Who is running the clinical trial?

University of Colorado, BoulderLead Sponsor
124 Previous Clinical Trials
29,432 Total Patients Enrolled
Douglas R Seals, PhDPrincipal InvestigatorUniversity of Colorado, Boulder
7 Previous Clinical Trials
573 Total Patients Enrolled

Media Library

High-resistance inspiratory muscle strength training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05000515 — N/A
High Blood Pressure Research Study Groups: High-resistance inspiratory muscle strength training, Aerobic exercise
High Blood Pressure Clinical Trial 2023: High-resistance inspiratory muscle strength training Highlights & Side Effects. Trial Name: NCT05000515 — N/A
High-resistance inspiratory muscle strength training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05000515 — N/A
~12 spots leftby Jun 2025